je.st
news
Tag: cancer
Tests for new cancer drugs not reliable enough, doctors say
2015-06-02 08:56:21| Biotech - Topix.net
CHICAGO: Drugmakers including Bristol-Myers Squibb Co and Merck & Co are testing which patients will most benefit from new cancer treatments based on a protein found in their tumors, but that guide, known as a biomarker, may be too unreliable, researchers and health experts said. Bristol's Opdivo and Merck's Keytruda are both therapies designed to block a protein known as Programmed Death receptor that tumors use to evade the body's natural defenses.
Tags: say
tests
cancer
reliable
Axalta Coating Systems Employees Get on Their Bikes for Belgian Cancer Charity Kom op tegen Kanker
2015-06-02 07:00:00| Coatings World Breaking News
Tags: op
systems
employees
cancer
Teen Girl Battling Cancer Hopes To 'Shake It Off' On Stage With Taylor Swift In Philly
2015-06-02 01:12:44| IT Services - Topix.net
After spending years in and out of Children's Hospital of Philadelphia undergoing numerous rounds of chemo, radiation and surgeries, HEADstrong says Jocelyn is the definition of a fighter. That is why the non-profit organization is sending the self-proclaimed "Swifty" to the Taylor Swift concert on June 12 at Lincoln Financial Field.
Teen Girl Battling Cancer Hopes To 'Shake It Off' On Stage With Taylor Swift In Philly
2015-06-02 01:12:43| IT Services - Topix.net
CBS 3 CBS 3 joined forces with the most trusted local CBS RADIO stations in Philadelphia to give you the best Philly has to offer. CBS 3 is part of CBS Television Stations, a division of CBS [...] KYW Newsradio 1060 Welcome to KYW Newsradio 1060 on CBSPhilly.com.
ASCO15: AngioChem Presents ANG1005 Data On Breast Cancer Patients...
2015-06-02 00:37:09| Logistics - Topix.net
Angiochem, a clinical stage biotechnology company creating and developing drugs that cross the blood-brain barrier, today announced that results from an ongoing multi-center Phase II study were presented on Saturday, May 30, 2015 at the 2015 American Society for Clinical Oncology annual meeting being held in Chicago. The trial was designed to evaluate the activity of ANG1005, a novel taxane-peptide conjugate able to cross the blood brain barrier and enter cancer cells by targeting the LRP-1 receptor, in metastatic breast cancer patients.
Tags: data
cancer
presents
patients
Sites : [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] next »